These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 3142090

  • 1. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of tissue plasminogen activator-induced fibrinolysis by activated protein C in endotoxin-treated rabbits.
    Krishnamurti C, Young GD, Barr CF, Colleton CA, Alving BM.
    J Lab Clin Med; 1991 Dec 08; 118(6):523-30. PubMed ID: 1744501
    [Abstract] [Full Text] [Related]

  • 6. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P, Koay ES, Tsakok M, Aw TC, Wong LY, Pradhan M.
    Thromb Haemost; 1988 Aug 30; 60(1):50-3. PubMed ID: 3142091
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 30; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 8. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EK.
    Thromb Haemost; 1992 Apr 02; 67(4):397-401. PubMed ID: 1631786
    [Abstract] [Full Text] [Related]

  • 9. Diurnal variation of the fibrinolytic system.
    Grimaudo V, Hauert J, Bachmann F, Kruithof EK.
    Thromb Haemost; 1988 Jun 16; 59(3):495-9. PubMed ID: 3142085
    [Abstract] [Full Text] [Related]

  • 10. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 11. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 08; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 12. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K, Vít L, Opatrná S, Sulková S, Bodláková B.
    Cas Lek Cesk; 1994 May 30; 133(11):346-9. PubMed ID: 8004664
    [Abstract] [Full Text] [Related]

  • 13. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
    Anglés-Cano E, Boutière B, Arnoux D, Masson C, Contant G, Benchimol P, Sampol J.
    Thromb Haemost; 1987 Oct 28; 58(3):843-9. PubMed ID: 3124285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.
    Carr ME, Krishnamurti C, Alving BM.
    Thromb Haemost; 1992 Jan 23; 67(1):106-10. PubMed ID: 1615464
    [Abstract] [Full Text] [Related]

  • 16. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Jan 23; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 23; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 20. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ, Derkx FH, Schalekamp MA, Dooijewaard G, vd Klaauw MM.
    Thromb Haemost; 1988 Jun 16; 59(3):404-11. PubMed ID: 3142078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.